Tafasitamab (XmAb5574) is an FC-modified humanized monoclonal antibody targeting the human B-cell surface antigen CD19 for the study of diffuse large B-cell lymphoma.
Purity:
95.50%
CAS Number:
[1422527-84-1]
Target:
Immunology/Inflammation related|||Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted